Identification and characterization of Nanobodies targeting the EphA4 receptor
Open Access
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (27) , 11452-11465
Abstract
No abstract availableKeywords
Funding Information
- Vlaams Instituut voor Biotechnologie
- KU Leuven (GOA/11/014)
- Fonds Wetenschappelijk Onderzoek (G.0996.14N, AUGE/09/040)
- Fondation Thierry Latran
- Seventh Framework Programme (259867)
- European Research Council (340429)
- Agentschap voor Innovatie door Wetenschap en Technologie (101318, 135043)
This publication has 74 references indexed in Scilit:
- Mechanisms of ephrin–Eph signalling in development, physiology and diseaseNature Reviews Molecular Cell Biology, 2016
- Therapeutic perspectives of Eph–ephrin system modulationDrug Discovery Today, 2014
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood–brain barrierProceedings of the National Academy of Sciences, 2013
- Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin ReceptorDrug Metabolism and Disposition, 2012
- A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after strokeProceedings of the National Academy of Sciences, 2012
- Nanobody stabilization of G protein-coupled receptor conformational statesCurrent Opinion in Structural Biology, 2011
- Structural Plasticity of Eph Receptor A4 Facilitates Cross-Class Ephrin SignalingStructure, 2009
- Single-domain antibodies as building blocks for novel therapeuticsCurrent Opinion in Pharmacology, 2008
- Regeneration‐enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cordEuropean Journal of Neuroscience, 2007